This is a Pilot Study Which Aims to Assess the Validity and Applicability of Lateral Flow Assays (LFAs) Which Can be Used as a Point of Care Test for COVID-19
Infectious Diseases
0
Pipeline Programs
1
Companies
1
Clinical Trials
0
Approved Products
Pipeline by Development Stage
Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket
Competitive Landscape
1 companies ranked by most advanced pipeline stage
Trial Timeline
Clinical trial activity over time
2021
2022
2023
2024
2025
2026
Alder TherapeuticsInnova Lateral Flow Device
Clinical Trials (1)
Total enrollment: 400 patients across 1 trials
The LAVA (Lateral Flow Antigen Validation and Applicability) Study for COVID-19
Start: Nov 2020Est. completion: Feb 2021400 patients
N/ACompleted
Related Jobs in Infectious Diseases
Senior Recruiter
Invivyd
New Haven, CT (Northeast preferred)
10h ago
$120K - $160K/yr
Senior Associate Scientist (contract), Upstream Polysaccharide Process Development
VaxCyte
San Carlos, California, United States
12h ago
$56/hr
Senior Associate Scientist (contract), Polysaccharide Analytical Development
VaxCyte
San Carlos, California, United States
13h ago
$56/hr
Director, Program Management
Metaphore Biotechnologies
Somerville, MA USA
16h ago
$179K - $237K/yr
Technician, Operations, DSP/ Technicien(ne) des opérations, DSP
Verona Pharma
CAN - Prince Edward Island - Charlottetown
Yesterday
$47K - $79K/yr
HVAC Maintenance Technician
Verona Pharma
USA - Delaware - Millsboro (Intervet)
Yesterday
Phase Legend
Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available
Key Insights
1 companies competing in this space